Elena Ciabatti

Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

Sara Galimberti, Stefano Luminari, Elena Ciabatti et al. · Clinical Cancer Research · 2014 · 112 citations · Full text

Hematological Malignancy, Pcr Status, Mrd Negativity +13

Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation

Sara Galimberti, E. Benedetti, Fortunato Morabito et al. · Leukemia Research · 2005 · 58 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +12

Boron nitride nanotubes and primary human osteoblasts:<i>in vitro</i>compatibility and biological interactions under low frequency ultrasound stimulation

Serena Danti, Gianni Ciofani, Stefania Moscato et al. · Nanotechnology · 2013 · 49 citations

Tissue Engineering, Mechanobiology, Boron Nitride +15

The c.480C&gt;G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia

Antonello Di Paolo, Marialuisa Polillo, Matteo Capecchi et al. · The Pharmacogenomics Journal · 2014 · 48 citations · Full text

Hematological Malignancy, Chronic Myeloid Leukemia, G Polymorphism +8

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow‐up Samples From Four Prospective Trials of the European MCL Network

Daniela Drandi, Marion Alcantara, Ichrafe Benmaad et al. · HemaSphere · 2020 · 44 citations · Full text